Roberto Filippi
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino(IT)University of Turin(IT)
Publications by Year
Research Areas
Cholangiocarcinoma and Gallbladder Cancer Studies, Colorectal Cancer Treatments and Studies, Gallbladder and Bile Duct Disorders, Pancreatic and Hepatic Oncology Research, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild‐type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti‐BIL study)(2015)139 cited
- → Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes(2020)110 cited
- → Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer(2014)77 cited
- → Fluoropyrimidine-induced cardiotoxicity(2018)66 cited
- → The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer(2019)57 cited
- → CT perfusion in solid-body tumours. Part I: technical issues(2010)47 cited